Skip to main content
SpringerLink
Log in

Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve

  • Assisted Reproduction Technologies
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Purposes

The aim of this study is to determine whether a clinical advantage is gained with use of LH in combination with FSH or as a component of human menopausal gonadotropin (hMG) to achieve optimal ovarian stimulation.

Methods

In this study, we compared retrospectively two regimens, r-FSH/r-LH and hMG, for the treatment of women with reduced ovarian reserve, identified as subjects with antral follicle count (AFC) < 11 and AMH ≤ 1.1 ng/ml.

Results

Overall, the clinical pregnancy per started cycle was higher in the r-FSH/r-LH group (12.5 vs. 8.1%, P < 0.02), while implantation (11.1 vs. 9.5%) and miscarriage rates (29.9 vs. 35.9%) were comparable. Data were further analysed performing separate comparisons in subpopulations with different ranges of AFC, i.e. < 4, 4–6 and 7–10. Major differences between the two regimens were observed in women with AFC < 4. In this subpopulation, not only was the clinical pregnancies per started cycle higher in the r-FSH/r-LH group (10.2 vs. 1.5%, P < 0.01), but also implantation was significantly higher (13.0 vs. 2.8%, P < 0.02).

Conclusions

A r-FSH/r-LH regimen appears to be beneficial for the treatment of women with extremely poor ovarian reserve. It should be considered however that, being retrospective, this study is affected by obvious limitations, such as post-treatment patient selection criteria and absence of randomisation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Orvieto R, Patrizio P. GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate. Reprod BioMed Online. Reproductive Healthcare Ltd. 2013;26:4–8.

    Article  CAS  PubMed  Google Scholar 

  2. Xiao J-S, Su C-M, Zeng X-T. Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis. Tian X, editor. PLoS One. Public Library of Science; 2014; 9:e106854.

  3. Fatemi HM, Popovic-Todorovic B, Humaidan P, Kol S, Banker M, Devroey P, et al. Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and “freeze-all” approach in GnRH antagonist protocol. Fertil Steril. 2014;101:1008–11.

    Article  CAS  PubMed  Google Scholar 

  4. Baerwald AR, Adams GP, Pierson RA. Ovarian antral folliculogenesis during the human menstrual cycle: a review. Hum Reprod Update. 2012;18:73–91.

    Article  PubMed  Google Scholar 

  5. Hillier SG, Smyth CD, Whitelaw PF, Miró F, Howles CM. Gonadotrophin control of follicular function. Horm Res. 1995;43:216–23.

    Article  CAS  PubMed  Google Scholar 

  6. Hillier SG. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol. 2001;179:39–46.

    Article  CAS  PubMed  Google Scholar 

  7. Ezcurra D, Humaidan P. A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology. Reprod Biol Endocrinol BioMed Central. 2014;12:95.

    Article  Google Scholar 

  8. Durnerin CI, Erb K, Fleming R, Hillier H, Hillier SG, Howles CM, et al. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation. Hum Reprod. 2008;23:421–6.

    Article  CAS  PubMed  Google Scholar 

  9. Revelli A, Pettinau G, Basso G, Carosso A, Ferrero A, Dallan C, et al. Controlled ovarian stimulation with recombinant-FSH plus recombinant-LH vs. human menopausal gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population. Reprod Biol Endocrinol. 2015;13:1–8.

    Article  CAS  Google Scholar 

  10. Vuong TNL, Phung HT, Ho MT. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial. Hum Reprod. 2015;30:1188–95.

    Article  CAS  PubMed  Google Scholar 

  11. Fábregues F, Creus M, Casals G, Carmona F, Balasch J. Outcome from consecutive ICSI cycles in patients treated with recombinant human LH and those supplemented with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol. Gynecol Endocrinol. 2013;29:430–5.

    Article  PubMed  Google Scholar 

  12. Pacchiarotti A, Sbracia M, Frega A, Selman H, Rinaldi L, Pacchiarotti A. Urinary hMG (Meropur) versus recombinant FSH plus recombinant LH (Pergoveris) in IVF: a multicenter, prospective, randomized controlled trial. Fertil Steril. 2010;94:2467–9.

    Article  CAS  PubMed  Google Scholar 

  13. Xiong Y, Bu Z, Dai W, Zhang M, Bao X, Sun Y. Recombinant luteinizing hormone supplementation in women undergoing in vitro fertilization/intracytoplasmic sperm injection with gonadotropin releasing hormone antagonist protocol: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2014;12:109–17.

  14. Howles C. Luteinizing hormone supplementation in ART. In: Kovacs G, editor. How to improve your ART success rates. Cambridge: Cambridge University Press; 2011. p. 99–104.

    Chapter  Google Scholar 

  15. Ubaldi FM, Rienzi L, Ferrero S, Baroni E, Sapienza F, Cobellis L, et al. Management of poor responders in IVF. Reprod BioMed Online. 2005;10:235–46.

    Article  CAS  PubMed  Google Scholar 

  16. Nelson SM. Biomarkers of ovarian response: current and future applications. Fertil Steril. 2013;99:963–9.

    Article  CAS  PubMed  Google Scholar 

  17. Ubaldi F, Vaiarelli A, D’Anna R, Rienzi L. Management of poor responders in IVF: is there anything new? Biomed Res Int. 2014;2014:1–10.

    Article  Google Scholar 

  18. Casarini L, Lispi M, Longobardi S, Milosa F, La Marca A, Tagliasacchi D, et al. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling. Gromoll J, editor. PLoS One. 2012;7:e46682.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Dahan MH, Agdi M, Shehata F, Son W, Tan SL. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis. Europ J Obstetr Gynecol Reprod Biol. 2014;172:70–3.

    Article  CAS  Google Scholar 

  20. Humaidan P, Chin W, Rogoff D, D'Hooghe T, Longobardi S, Hubbard J, et al. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders. Hum Reprod. Oxford University Press; 2017; 32:1–12.

  21. Lehert P, Schertz JC, Ezcurra D. Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis. Reprod Biol Endocrinol. 2010;8:112.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26:1768–74.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biogenesi Reproductive Medicine Centre, Istituti Clinici Zucchi, Via Zucchi, 24, Monza, Italy

    Mario Mignini Renzini, Claudio Brigante, Giovanni Coticchio, Mariabeatrice Dal Canto, Ilaria Caliari, Ruggero Comi & Rubens Fadini

  2. Department of Medical Physics, ASST Monza, Monza, Italy

    Elena De Ponti

Authors
  1. Mario Mignini Renzini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudio Brigante
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giovanni Coticchio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mariabeatrice Dal Canto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ilaria Caliari
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ruggero Comi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Elena De Ponti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rubens Fadini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Coticchio.

Ethics declarations

The study was approved by the competent ethical committee (San Gerardo Hospital, Monza, Italy). Written informed consent was obtained from all couples before starting treatment.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mignini Renzini, M., Brigante, C., Coticchio, G. et al. Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve. J Assist Reprod Genet 34, 1645–1651 (2017). https://doi.org/10.1007/s10815-017-1034-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-017-1034-z

Keywords

Search

Navigation